(702) 683-8946

Monday - Friday 9am to 5pm

triangle
ad1

http://crweworld.com/assets/images/ad/content-delivery-solution.jpg

Our content delivery solution through CRWE WORLDCRWE Press Release and CRWE Tubegives corporations and businesses a vehicle to expand their exposure

Content Delivery Solution (Learn More)

ad3

https://crweworld.com/assets/img/crwe_info.png

CRWE Info ( CRWE.Info ) provides news and updates about Crown Equity Holdings Inc. and the CRWE World platform

www.crwe.info

ad4

https://crweworld.com/assets/images/ad/submit_a_press_release.jpg

Submit Your Press Release/News to the CRWE WORLD Network!. Increase Visibility, Boost Your Business

www.CRWEPressRelease.com






Latest News Releases From The Newsroom

Earnings Preview, Key Expectations: Hello Group, Yext, Couchbase, G-III Apparel, Chico's FAS

June 04th, 2023

Several companies are expected to report their financial results on Tuesday, June 6, providing insights into their performance and market trends. Hello Group Inc. (Nasdaq: MOMO), a leading social networking platform, will release its unaudited fin. Read more

NewAmsterdam, Acrivon, Veeva Systems, Amprius Technologies: Latest Updates, Potential Upsides

June 04th, 2023

NewAmsterdam Pharma Company N.V. (Nasdaq: NAMS) released the comprehensive findings from the ROSE2 Phase 2 clinical trial, which examined the efficacy of obicetrapib, their oral, low-dose cholesteryl ester transfer protein inhibitor, in conjunction w. Read more

Financial Results Preview: Academy Sports, ABM Industries, Cracker Barrel, and ReNew Energy

June 04th, 2023

Several companies are set to release their financial results on Tuesday, June 6, including: Academy Sports and Outdoors, Inc. (Nasdaq: ASO), a leading sporting goods and outdoor recreation retailer, is set to announce its first-quarter fiscal 2023. Read more

Evaxion Biotech: Promising EVX-01 Clinical Data; Celsius, Accenture, Five Below: PT Raised

June 04th, 2023

Evaxion Biotech A/S (Nasdaq: EVAX) announced encouraging findings from its EVX-01 Phase 1 clinical trial, which assessed the safety and effectiveness of EVX-01 in combination with a checkpoint inhibitor for metastatic melanoma patients.  Acco. Read more

Market Buzz: Profitability Projections for Ferguson plc, Casey's, Ciena, Core & Main and THOR Industries

June 03rd, 2023

Several companies are scheduled to report their financial results on Tuesday, June 6. Ferguson plc (NYSE: FERG), a global distributor of plumbing and heating products, will release its third-quarter fiscal 2023 results before the market opens. Ana. Read more

Lockheed Martin Space Awarded $122.2M Contract, AvidXchange, Cosan, Flywire Get Price Target Boosts

June 03rd, 2023

Lockheed Martin Space, a prominent division of Lockheed Martin Corporation (NYSE: LMT), has secured a significant contract modification worth $122,213,602.  The modification, designated as P00102 under contract FA8810-18-C-0005, aims to facil. Read more

Key Players Set to Reveal Performance Figures: GitLab, SAIC, HealthEquity, Sprinklr, JOANN and Fusion Fuel Green

June 03rd, 2023

Several companies are set to report their financial results on Monday, June 5. GitLab Inc. (Nasdaq: GTLB), a software development platform, will release its first-quarter fiscal year 2024 financial results after the U.S. markets close. The consens. Read more

S&P 500 Boosts Palo Alto Networks, Price Target Hiked: Apple, Tonix Pharmaceuticals, Ryanair, Aflac

June 03rd, 2023

Palo Alto Networks Inc. (Nasdaq: PANW) is set to join the prestigious S&P 500 index, replacing DISH Network Corp. (Nasdaq: DISH), starting from Tuesday, June 20.  The S&P 500 is widely regarded as a benchmark for the U.S. stock market, compri. Read more

The U.S. National Strategy to Counter Antisemitism: Key Actions by Pillar

June 03rd, 2023

JUNE 02, 2023 -  The Biden-Harris Administration released the U.S. National Strategy to Counter Antisemitism on May 25, 2023. The strategy outlines a whole-of-society approach to tackle the scourge of antisemitism in America.. Read more

Jazz Pharma, Zymeworks: Promising Data on Zanidatamab in HER2-Amplified BTC; Positive View on Trade Desk, Kura Sushi and Surgery Partners

June 03rd, 2023

Jazz Pharmaceuticals plc (Nasdaq: JAZZ) and Zymeworks Inc. (Nasdaq: ZYME) shared encouraging results from the pivotal Phase 2b HERIZON-BTC-01 trial, which assessed the efficacy of Zanidatamab, an investigational bispecific antibody developed on Zymew. Read more